[144] Procter & Gamble Company SEC Filing

Rhea-AI Filing Summary

The filing is a Form 144 notice reporting a proposed sale of 10,094 shares of Procter & Gamble Company common stock through Morgan Stanley Smith Barney LLC on the New York Stock Exchange, with an aggregate market value of $1,563,611.07, and an approximate sale date of 08/19/2025. The shares were acquired on 08/18/2025 under a Performance Stock Program Award from Procter & Gamble and 21,372 shares are shown as the amount acquired on that date for the award. The filer represents they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Transparent compliance: The filer disclosed the proposed sale under Rule 144 and included broker, share count, market value, and sale date.
• Transaction originated from compensation: Shares were acquired via a Performance Stock Program Award, indicating this was a routine compensation-related disposition.

Negative

• None.

Insights

Securities Analyst

TL;DR Routine Rule 144 notice disclosing an insider sale of ~10k shares valued at $1.56M; procedural and non-material to company financials.

The filing documents a planned sale under Rule 144 executed through a broker on the NYSE, indicating compliance with Regulation-based resale requirements for restricted or control securities. The size of the sale relative to Procter & Gamble’s outstanding shares (2,342,371,488 reported) is de minimis, so there is no expected impact on capital structure or public float. The transaction arose from a Performance Stock Program Award vested/acquired on 08/18/2025, with payment noted the same day. No prior sales in the past three months are reported.

Corporate Governance Specialist

TL;DR Proper disclosure of an executive/insider sale under Rule 144; indicates adherence to insider sale procedures without revealing strategic signals.

The notice includes standard attestations about absence of undisclosed material information and references trading-plan provisions. This form is a compliance document rather than a strategic disclosure; it records the mechanics of an insider disposing of award shares through an approved broker. There is no accompanying information about a trading plan date or other explanatory remarks, limiting further governance interpretation.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	10094	1563611.07	2342371488	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/18/2025	Performance Stock Program Award	The Procter & Gamble Company			21372	08/18/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Procter & Gamble (PG) report?

The Form 144 reports a proposed sale of 10,094 shares of PG common stock valued at $1,563,611.07 to be sold on 08/19/2025 on the NYSE through Morgan Stanley Smith Barney LLC.

When were the shares being sold acquired and how?

The shares were acquired on 08/18/2025 under a Performance Stock Program Award from The Procter & Gamble Company.

How many shares outstanding did the filing show for Procter & Gamble?

The filing lists 2,342,371,488 shares outstanding for the issuer.

Does the filing report any sales of issuer securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Who is the broker named for the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, 38th Floor, New York, NY.